1 year RV/TLC change as a predictor of long term decline of FEV1

I. Kim (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), Y. Hwang (An-Yang, Republic of Korea), K. Yoo (Seoul, Republic of Korea)

Source: International Congress 2018 – Biomarkers of COPD
Session: Biomarkers of COPD
Session type: Thematic Poster
Number: 4074
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Kim (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea), Y. Hwang (An-Yang, Republic of Korea), K. Yoo (Seoul, Republic of Korea). 1 year RV/TLC change as a predictor of long term decline of FEV1. 4074

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017


Prediction of all cause mortality in a population sample is improved by using FEV1 quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Re-assessing the importance of FEV1 decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015


Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016



LVRS does not accelerate rate of decline in FEV1
Source: Eur Respir J 2003; 22: Suppl. 45, 369s
Year: 2003

Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010


The correlation of annual rate of FEV1 decline with the temperature of expired air in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008

Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012


Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016


Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


The relationship between long-term correlations (self-similarity) in PEF and FEV1 in COPD
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

Impact of the body mass index on the FEV1 value and its mean yearly decline in COPD patients
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


Impact of baseline desaturation during a six minute walk test (6MWT) on prognostic value of subsequent changes in FVC and DLCO
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


The effect of stop smoking on FEV1 and FEV1/FVC
Source: Eur Respir J 2003; 22: Suppl. 45, 307s
Year: 2003

The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001

Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients
Source: Eur Respir J 2009; 34: 776
Year: 2009


The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021